Country/Region: China State/Province: Beijing
Main Products: DXM, Dextromethorphan Hydrobromide, Phenazepam, Mdai, 6 Apb, 5iai, Zopiclone
Business Type: Manufacturer, Buying House
Year Established: 2000
Employees: Above 1000 People
Plant Area: 10,000-30,000 square meters
Main Markets: South America 12% Africa 12% Eastern Asia 10% Domestic Market 12% North America 8% Eastern Europe 11% Southern Europe 10% Mid East 10% Northern Europe 9% Oceania 6%
Trade Capacity: FOB, FCA, DDU
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Beijing
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: US$10 Million - US$50 Million
Export Revenue: Below US$1 Million
Annual Output: US$2.5 Million - US$5 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 61% - 70%
Payment Modes: USD, JPY, HKD
Lead Time: 32 days
Import/Export Mode: Have Own Export License